MultiBiopsy ApS

CVR 44304554 · Private limited company (ApS) · Active · Medium risk

MultiBiopsy ApS is a Private limited company (ApS), founded on , based in Aarhus C. The company is registered in the industry fremstilling af medicinske og dentale instrumenter samt udstyr hertil. Our model estimates a bankruptcy risk of 1.6% over the next 12 months, which is 1.1 times the average for Danish companies. 2 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 64k and a net result of DKK -2,337. CEO: William Hans Jul Vindal Ludvigsen.

Bankruptcy risk for MultiBiopsy ApS

1.6%
probability of bankruptcy within 12 months
Medium risk

1.1 × the average (1.41%) · higher risk than 79% of active Danish companies

Lowest riskHighest risk

Increases the risk

Moves in the last 2 years2 · bankruptcy rate 23.9%2.7×
Share of late annual reports50%–75% · bankruptcy rate 18.4%2.1×
Published annual reports2 · bankruptcy rate 16.7%1.9×
Time at current address0.5–1 yrs · bankruptcy rate 16.5%1.9×
Time since new CEO1 yrs · bankruptcy rate 16.2%1.8×
Age (years)3–5 yrs · bankruptcy rate 13.3%1.5×
Equity vs. share capital1× · bankruptcy rate 12.9%1.5×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×

Reduces the risk

Negative equityNo · bankruptcy rate 5.1%0.58×
Auditor's statementCompilation · bankruptcy rate 5.6%0.64×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×
Return on assets-20%–0% · bankruptcy rate 6.2%0.70×
Gross profit growth-30%–-10% · bankruptcy rate 6.3%0.71×
Going-concern uncertaintyNo · bankruptcy rate 6.4%0.73×
RegionMidtjylland · bankruptcy rate 6.9%0.79×
Qualification / emphasis of matterNo · bankruptcy rate 7.1%0.80×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
44304554
Status
Active
Company type
Private limited company (ApS)
Founded
(3 years)
Address
c/o Kitchen, Universitetsbyen 76
8000 Aarhus C
Municipality
Aarhus
Industry
Fremstilling af medicinske og dentale instrumenter samt udstyr hertil (325000)
Bankruptcies in the industry: Fremstilling af medicinske og dentale instrumenter samt udstyr hertil
Share capital
DKK 40k
Auditor
Dansk Revision Benny Jakobsen
Audit opted out
Yes

Warning signs

Annual reports filed late1 of 2
Missing annual reportNo
Negative equityNo
Equity ratio18.0%
Current ratio81%
Moves (last 2 years)2
CEO changes in total2
CEO's previous bankruptcies0
Other companies at the address12
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK 528kDKK 591k
Net profitDKK -2,337DKK 26k
EquityDKK 64kDKK 66k
Total assetsDKK 353kDKK 234k
CashDKK 0–
Short-term debtDKK 289k–
Avg. employees4–

Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Dansk Revision Benny Jakobsen.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025183
12 Sep 2023 – 31 Dec 2024162

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOWilliam Hans Jul Vindal LudvigsenCurrent
CEOKristian Horsager
Owner (100%)MultiBiopsy Holding ApSCurrent
FounderMultiBiopsy Holding ApSCurrent

The CEOs' other companies

William Hans Jul Vindal Ludvigsen – 2 other companies

Kristian Horsager – 1 other companies

Address history (3 moves)

c/o Kitchen, Universitetsbyen 76, 8000 Aarhus C
c/o The Kitchen, Universitetsbyen 14, 8000 Aarhus C
Åbogade 15, 8200 Aarhus N
Oktobervej 10, 8210 Aarhus V

Other companies at the same address

Similar companies in Aarhus

Questions and answers about MultiBiopsy ApS

Has MultiBiopsy ApS gone bankrupt?

No, MultiBiopsy ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of MultiBiopsy ApS?

Our model estimates a bankruptcy risk of 1.6% over the next 12 months (medium risk), which is 1.1 times the average for Danish companies.

Who is the CEO of MultiBiopsy ApS?

William Hans Jul Vindal Ludvigsen is the CEO of MultiBiopsy ApS.

Who is the auditor of MultiBiopsy ApS?

MultiBiopsy ApS most recently used Dansk Revision Benny Jakobsen.

When was MultiBiopsy ApS founded?

MultiBiopsy ApS was founded on 12 September 2023.

What is the equity of MultiBiopsy ApS?

Equity was DKK 64k according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.